Folliculin regulates ampk-dependent autophagy and metabolic stress survival

Elite Possik1, Zahra Jalali1, Yann Nouët1

  • 1Goodman Cancer Research Center, McGill University, Montréal, Québec, Canada; Department of Biochemistry, McGill University, Montréal, Québec, Canada.

Plos Genetics
|April 26, 2014
PubMed

Insights

Folliculin (FLCN) negatively regulates AMP-activated protein kinase (AMPK). Loss of FLCN causes constitutive AMPK activation, promoting cell survival and stress resistance, suggesting FLCN’s tumor suppressor role.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Genetics

Background:

  • AMP-activated protein kinase (AMPK) signaling is crucial in human diseases.
  • Dysregulated AMPK is linked to various pathologies, highlighting the need to understand its regulators.
  • The tumor suppressor Folliculin (FLCN), linked to Birt-Hogg Dubé syndrome, interacts with AMPK, but their functional relationship is unclear.

Purpose of the Study:

  • To investigate the genetic and functional links between Folliculin (FLCN) and AMP-activated protein kinase (AMPK).
  • To determine the role of FLCN in regulating AMPK signaling and its implications in cellular processes and disease.
  • To establish FLCN as a tumor suppressor by elucidating its mechanism involving AMPK.

Main Methods:

  • Utilized Caenorhabditis elegans and mammalian cell models.
  • Investigated the effects of FLCN loss on AMPK activity and downstream cellular responses.
  • Assessed cellular bioenergetics, apoptosis, autophagy, and stress resistance under various conditions.

Main Results:

  • Folliculin (FLCN) acts as an evolutionarily conserved negative regulator of AMPK.
  • Loss of FLCN leads to constitutive AMPK activation, independent of cellular energy status.
  • FLCN-deficient cells exhibit enhanced autophagy, inhibited apoptosis, improved bioenergetics, and increased resistance to diverse stresses.

Conclusions:

  • FLCN is a critical regulator of AMPK energy sensing and signaling.
  • FLCN may function as a tumor suppressor by inhibiting AMPK.
  • Understanding the FLCN-AMPK axis provides insights into Birt-Hogg Dubé syndrome pathogenesis and potential therapeutic strategies.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
99
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.2K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.3K